Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−5.7251 USD
−20.66 M USD
0.00 USD
9.95 M
About Oragenics Inc.
Sector
CEO
Janet Huffman
Headquarters
Tampa
Website
Founded
1996
FIGI
BBG000PTF8K2
Oragenics, Inc. operates as a development-stage company, which engages in research and development of potential therapies to fight infectious diseases including coronaviruses and multidrug-resistant organisms. Its technology and pipeline consist of antibiotics and genetically engineered bacterial strains. The company was founded by Jeffrey D. Hillman and Robert T. Zahradnik in November 1996 and is headquartered in Tampa, FL.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of OGEN is 0.3920 USD — it has increased by 3.42% in the past 24 hours. Watch Oragenics Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on AMEX exchange Oragenics Inc. stocks are traded under the ticker OGEN.
OGEN stock has risen by 12.97% compared to the previous week, the month change is a 29.01% rise, over the last year Oragenics Inc. has showed a −92.54% decrease.
OGEN reached its all-time high on Nov 3, 2003 with the price of 58,800.0000 USD, and its all-time low was 0.2542 USD and was reached on Nov 19, 2024. View more price dynamics on OGEN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
OGEN stock is 12.03% volatile and has beta coefficient of 3.28. Track Oragenics Inc. stock price on the chart and check out the list of the most volatile stocks — is Oragenics Inc. there?
Today Oragenics Inc. has the market capitalization of 4.75 M, it has increased by 19.71% over the last week.
Yes, you can track Oragenics Inc. financials in yearly and quarterly reports right on TradingView.
Oragenics Inc. is going to release the next earnings report on Feb 14, 2025. Keep track of upcoming events with our Earnings Calendar.
OGEN net income for the last quarter is −2.46 M USD, while the quarter before that showed −2.31 M USD of net income which accounts for −6.84% change. Track more Oragenics Inc. financial stats to get the full picture.
No, OGEN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 27, 2024, the company has 5.00 employees. See our rating of the largest employees — is Oragenics Inc. on this list?
Like other stocks, OGEN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Oragenics Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Oragenics Inc. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Oragenics Inc. stock shows the sell signal. See more of Oragenics Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.